Labcorp Holdings ROE 2010-2025 | LH
Current and historical return on equity (ROE) values for Labcorp Holdings (LH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Labcorp Holdings ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $0.76B | $8.47B | 9.25% |
| 2025-03-31 | $0.73B | $8.31B | 8.97% |
| 2024-12-31 | $0.75B | $8.05B | 9.26% |
| 2024-09-30 | $0.44B | $8.17B | 5.44% |
| 2024-06-30 | $0.45B | $8.01B | 5.66% |
| 2024-03-31 | $0.43B | $7.96B | 5.33% |
| 2023-12-31 | $0.42B | $7.88B | 4.79% |
| 2023-09-30 | $0.66B | $7.87B | 7.13% |
| 2023-06-30 | $0.83B | $8.79B | 8.45% |
| 2023-03-31 | $1.00B | $10.34B | 9.78% |
| 2022-12-31 | $1.28B | $10.10B | 12.39% |
| 2022-09-30 | $1.76B | $10.09B | 16.94% |
| 2022-06-30 | $1.99B | $10.40B | 19.00% |
| 2022-03-31 | $2.10B | $10.72B | 20.10% |
| 2021-12-31 | $2.38B | $10.27B | 23.15% |
| 2021-09-30 | $2.76B | $10.53B | 27.46% |
| 2021-06-30 | $2.88B | $10.25B | 30.34% |
| 2021-03-31 | $2.64B | $10.02B | 30.16% |
| 2020-12-31 | $1.56B | $9.44B | 19.42% |
| 2020-09-30 | $0.85B | $8.24B | 11.20% |
| 2020-06-30 | $0.36B | $7.35B | 4.98% |
| 2020-03-31 | $0.32B | $7.02B | 4.43% |
| 2019-12-31 | $0.82B | $7.57B | 11.34% |
| 2019-09-30 | $0.76B | $7.23B | 10.61% |
| 2019-06-30 | $0.85B | $7.14B | 11.98% |
| 2019-03-31 | $0.90B | $7.11B | 12.65% |
| 2018-12-31 | $0.88B | $6.97B | 12.52% |
| 2018-09-30 | $1.41B | $7.25B | 20.15% |
| 2018-06-30 | $1.27B | $7.04B | 18.80% |
| 2018-03-31 | $1.22B | $6.98B | 18.89% |
| 2017-12-31 | $1.23B | $6.80B | 20.08% |
| 2017-09-30 | $0.70B | $6.13B | 12.16% |
| 2017-06-30 | $0.71B | $5.88B | 12.63% |
| 2017-03-31 | $0.73B | $5.65B | 13.30% |
| 2016-12-31 | $0.71B | $5.51B | 13.24% |
| 2016-09-30 | $0.66B | $5.52B | 12.56% |
| 2016-06-30 | $0.63B | $5.31B | 12.45% |
| 2016-03-31 | $0.60B | $5.17B | 12.10% |
| 2015-12-31 | $0.44B | $4.95B | 9.15% |
| 2015-09-30 | $0.45B | $4.91B | 10.53% |
| 2015-06-30 | $0.43B | $4.77B | 11.56% |
| 2015-03-31 | $0.40B | $4.52B | 12.56% |
| 2014-12-31 | $0.51B | $2.82B | 19.02% |
| 2014-09-30 | $0.52B | $2.77B | 19.85% |
| 2014-06-30 | $0.53B | $2.66B | 20.68% |
| 2014-03-31 | $0.54B | $2.50B | 21.09% |
| 2013-12-31 | $0.57B | $2.49B | 21.83% |
| 2013-09-30 | $0.57B | $2.57B | 21.15% |
| 2013-06-30 | $0.57B | $2.66B | 20.86% |
| 2013-03-31 | $0.57B | $2.78B | 20.95% |
| 2012-12-31 | $0.58B | $2.72B | 21.87% |
| 2012-09-30 | $0.60B | $2.72B | 22.89% |
| 2012-06-30 | $0.58B | $2.63B | 22.73% |
| 2012-03-31 | $0.55B | $2.60B | 21.67% |
| 2011-12-31 | $0.52B | $2.50B | 20.70% |
| 2011-09-30 | $0.52B | $2.54B | 20.66% |
| 2011-06-30 | $0.52B | $2.58B | 21.49% |
| 2011-03-31 | $0.55B | $2.40B | 23.67% |
| 2010-12-31 | $0.56B | $2.47B | 24.56% |
| 2010-09-30 | $0.57B | $2.27B | 26.08% |
| 2010-06-30 | $0.56B | $2.21B | 26.39% |
| 2010-03-31 | $0.54B | $2.16B | 26.16% |
| 2009-12-31 | $0.54B | $2.11B | 27.28% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $23.210B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.791B | 27.22 |
| CVS Health (CVS) | United States | $91.231B | 11.35 |
| Elevance Health (ELV) | United States | $69.762B | 9.38 |
| Cencora (COR) | United States | $56.333B | 18.76 |
| DiDi Global (DIDIY) | China | $26.403B | 28.05 |
| Natera (NTRA) | United States | $22.377B | 0.00 |
| BioMerieux (BMXMF) | France | $17.423B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.898B | 0.00 |
| ICON (ICLR) | Ireland | $14.052B | 13.52 |
| Medpace Holdings (MEDP) | United States | $13.301B | 35.20 |
| CochLear (CHEOY) | Australia | $12.977B | 0.00 |
| Solventum (SOLV) | United States | $12.638B | 13.04 |
| Viatris (VTRS) | United States | $12.148B | 4.32 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.748B | 0.00 |
| Revvity (RVTY) | United States | $10.283B | 18.12 |
| Avantor (AVTR) | United States | $8.992B | 13.19 |
| Charles River Laboratories (CRL) | United States | $8.012B | 15.20 |
| Sonic Healthcare (SKHHY) | Australia | $7.799B | 0.00 |
| HealthEquity (HQY) | United States | $7.608B | 33.33 |
| Bausch + Lomb (BLCO) | Canada | $5.151B | 34.64 |
| Sotera Health (SHC) | United States | $4.687B | 26.19 |
| BrightSpring Health Services (BTSG) | United States | $4.239B | 32.34 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.711B | 84.99 |
| Alignment Healthcare (ALHC) | United States | $3.196B | 0.00 |
| Concentras Parent (CON) | United States | $2.993B | 18.98 |
| Surgery Partners (SGRY) | United States | $2.926B | 36.81 |
| Organon (OGN) | United States | $2.392B | 2.61 |
| KindlyMD (NAKA) | United States | $2.377B | 0.00 |
| Premier (PINC) | United States | $2.161B | 20.04 |
| Progyny (PGNY) | United States | $1.979B | 41.85 |
| Ardent Health (ARDT) | United States | $1.819B | 7.02 |
| PACS (PACS) | United States | $1.807B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.564B | 26.47 |
| Pediatrix Medical (MD) | United States | $1.496B | 9.99 |
| Teladoc Health (TDOC) | United States | $1.368B | 0.00 |
| Omada Health (OMDA) | $1.343B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.230B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.853B | 5.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.771B | 9.53 |
| CareDx (CDNA) | United States | $0.707B | 13.03 |
| Performant Healthcare (PHLT) | United States | $0.599B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 100.00 |
| Agilon Health (AGL) | United States | $0.539B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| Nutex Health (NUTX) | United States | $0.499B | 7.55 |
| Sonida Senior Living (SNDA) | United States | $0.493B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 6.99 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.453B | 0.00 |
| SBC Medicals (SBC) | United States | $0.434B | 9.50 |
| Enhabit (EHAB) | United States | $0.406B | 26.67 |
| So-Young (SY) | China | $0.399B | 0.00 |
| Oncology Institute (TOI) | United States | $0.324B | 0.00 |
| LifeMD (LFMD) | United States | $0.304B | 0.00 |
| Beauty Health (SKIN) | United States | $0.260B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.240B | 0.00 |
| DocGo (DCGO) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.158B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Biodesix (BDSX) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.036B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| ModivCare (MODV) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |